This trial results were presented at the 33rd EADV Congress 2024 in Amsterdam, by Drs Jonathan I. Silverberg, Lawrence Eichenfield, Andrew Blauvelt et al from

This trial result was presented at the 33rd EADV Congress 2024 in Amsterdam, by Drs Rodney Sinclair, Bianca Maria Piraccini, Laurent Misery et al from

This case report was presented at the 33rd EADV Congress 2024 in Amsterdam, by Drs Arij Lissir, Faten Rabhi, et al from the Military Hospital

In a series of enlightening presentations at the recent 33rd EADV Congress 2024, leading experts in the field of urticaria and angioedema shared cutting-edge research

In a series of exciting presentations at the 33rd EADV Congress 2024 leading experts in the field of atopic dermatitis (AD) shared cutting-edge research and

In a groundbreaking series of presentations at the 33rd EADV Congress 2024 on September 26th leading experts in the field of trichology shared cutting-edge research

In a exciting session at the EADV Congress 2024, leading experts unveiled the latest advancements and future prospects of Janus Kinase (JAK) inhibitors in treating

This study was presented at the 33rd EADV Congress 2024 by Drs Sabine Zenker et al from the Dr Zenker Dermatology, Munich, Germany. In a

This study was presented at the 33rd EADV Congress 2024 by Drs Carolina Montero- Vilchez et al from the Virgen de las Nieves University Hospital,

This Case report was presented at the 33rd EADV Congress 2024 by Drs Letícia Scattone et al from the Complexo Hospitalar Heliópolis, São Paulo, Brazil.